While there is no current meta‐analysis or population‐wide study restricting the estimate of the effect of APOE4 on incident MCI, we believe it is unlikely that the estimate will be greater than 1.77 after adjusting for age, sex, education, race, and AD biomarkers and explain away our effect estimates. The gene discussed is APOE; the disease is Alzheimer disease.